- Home
- APM vs CELZ Comparison
APM vs CELZ Comparison
Compare APM & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- CELZ
- Stock Information
- Founded
- APM 2010
- CELZ 1998
- Country
- APM United Kingdom
- CELZ United States
- Employees
- APM N/A
- CELZ N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- APM Health Care
- CELZ Health Care
- Exchange
- APM Nasdaq
- CELZ Nasdaq
- Market Cap
- APM 5.6M
- CELZ 5.5M
- IPO Year
- APM 2018
- CELZ N/A
- Fundamental
- Price
- APM $0.99
- CELZ $1.93
- Analyst Decision
- APM
- CELZ
- Analyst Count
- APM 0
- CELZ 0
- Target Price
- APM N/A
- CELZ N/A
- AVG Volume (30 Days)
- APM 138.3K
- CELZ 100.5K
- Earning Date
- APM 05-06-2025
- CELZ 05-09-2025
- Dividend Yield
- APM N/A
- CELZ N/A
- EPS Growth
- APM N/A
- CELZ N/A
- EPS
- APM 0.00
- CELZ N/A
- Revenue
- APM N/A
- CELZ $11,000.00
- Revenue This Year
- APM $157,729.10
- CELZ N/A
- Revenue Next Year
- APM N/A
- CELZ N/A
- P/E Ratio
- APM $270.99
- CELZ N/A
- Revenue Growth
- APM N/A
- CELZ 22.22
- 52 Week Low
- APM $0.46
- CELZ $1.69
- 52 Week High
- APM $7.49
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- APM 51.54
- CELZ 38.56
- Support Level
- APM $0.79
- CELZ $1.90
- Resistance Level
- APM $0.97
- CELZ $2.10
- Average True Range (ATR)
- APM 0.12
- CELZ 0.24
- MACD
- APM 0.02
- CELZ 0.06
- Stochastic Oscillator
- APM 33.74
- CELZ 36.49
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.